The terms we, us, our, Dar or the Company refer collectively to Dar Bioscience, Inc. and its wholly-owned subsidiaries, unless otherwise stated or the context otherwise requires. All information in this report is based on our fiscal year. Unless otherwise stated, references to particular years, quarters, months or periods refer to our fiscal years ending December 31 and the associated quarters, months and periods of those fiscal years. Overview We are a purpose-driven health biotech company sole...
Q2 FY2026 — expected 2026-09-13
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001401914-26-000004 | EDGAR | 136K words |
| 2025-03-31 | 2024-12-31 | 0001401914-25-000012 | EDGAR | — |
| 2024-03-28 | 2023-12-31 | 0001401914-24-000016 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0001401914-23-000013 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001401914-22-000032 | EDGAR | — |
| 2021-03-30 | 2020-12-31 | 0001401914-21-000041 | EDGAR | — |
| 2020-03-27 | 2019-12-31 | 0001401914-20-000042 | EDGAR | — |
| 2019-04-01 | 2018-12-31 | 0001401914-19-000015 | EDGAR | — |
| 2018-03-28 | 2017-12-31 | 0001564590-18-006989 | EDGAR | — |
| 2017-03-31 | 2016-12-31 | 0001564590-17-005798 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001401914-25-000050 | EDGAR | 32K words |
| 2025-08-14 | 2025-06-30 | 0001401914-25-000044 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001401914-25-000022 | EDGAR | — |
| 2024-11-14 | 2024-09-30 | 0001401914-24-000041 | EDGAR | — |
| 2024-08-12 | 2024-06-30 | 0001401914-24-000038 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0001401914-24-000033 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0001401914-23-000048 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001401914-23-000045 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001401914-23-000023 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001401914-22-000087 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001401914-22-000075 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001401914-22-000051 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-26 | 0001493152-26-012902 | EDGAR | 5K words |
| 2026-03-17 | 0001493152-26-010594 | EDGAR | — |
| 2026-03-09 | 0001493152-26-009364 | EDGAR | — |
| 2026-03-02 | 0001493152-26-008451 | EDGAR | — |
| 2026-01-29 | 0001493152-26-004245 | EDGAR | — |
| 2026-01-06 | 0001493152-26-000513 | EDGAR | — |
| 2025-12-01 | 0001493152-25-025491 | EDGAR | — |
| 2025-11-13 | 0001493152-25-022277 | EDGAR | — |
| 2025-09-02 | 0001493152-25-012516 | EDGAR | — |
| 2025-08-14 | 0001641172-25-023971 | EDGAR | — |
307 total filings indexed. 275 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001401914 |
| Ticker | DARE |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.darebioscience.com |
| Listed | 2014-04-10 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report